» Articles » PMID: 38205346

Mesenchymal Stromal Cell Delivery Via Cardiopulmonary Bypass Provides Neuroprotection in a Juvenile Porcine Model

Abstract

Oxidative/inflammatory stresses due to cardiopulmonary bypass (CPB) cause prolonged microglia activation and cortical dysmaturation, thereby contributing to neurodevelopmental impairments in children with congenital heart disease (CHD). This study found that delivery of mesenchymal stromal cells (MSCs) via CPB minimizes microglial activation and neuronal apoptosis, with subsequent improvement of cortical dysmaturation and behavioral alteration after neonatal cardiac surgery. Furthermore, transcriptomic analyses suggest that exosome-derived miRNAs may be the key drivers of suppressed apoptosis and STAT3-mediated microglial activation. Our findings demonstrate that MSC treatment during cardiac surgery has significant translational potential for improving cortical dysmaturation and neurological impairment in children with CHD.

Citing Articles

The role of microglia in Neuroinflammation associated with cardiopulmonary bypass.

Meng L, Gu T, Yu P, Zhang Z, Wei Z Front Cell Neurosci. 2025; 18:1496520.

PMID: 39742156 PMC: 11685197. DOI: 10.3389/fncel.2024.1496520.


Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair.

Kobayashi K, Kobayashi K, Liu C, Ryan J, Zurakowski D, Ishibashi N Pediatr Cardiol. 2024; .

PMID: 38918239 PMC: 11668907. DOI: 10.1007/s00246-024-03550-5.


Can Mesenchymal Stem Cell-Derived Therapeutics Protect the Developing Brain During Cardiac Surgery?.

Hansmann G JACC Basic Transl Sci. 2024; 8(12):1536-1538.

PMID: 38205354 PMC: 10774766. DOI: 10.1016/j.jacbts.2023.08.012.

References
1.
Chen S, Dong Z, Cheng M, Zhao Y, Wang M, Sai N . Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation. 2017; 14(1):187. PMC: 5604224. DOI: 10.1186/s12974-017-0963-x. View

2.
Okamura T, Ishibashi N, Kumar T, Zurakowski D, Iwata Y, Lidov H . Hypothermic circulatory arrest increases permeability of the blood brain barrier in watershed areas. Ann Thorac Surg. 2010; 90(6):2001-8. PMC: 3043641. DOI: 10.1016/j.athoracsur.2010.06.118. View

3.
Hanley P, Mei Z, Durett A, Cabreira-Hansen M, Cabreira-Harrison M, Klis M . Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. Cytotherapy. 2014; 16(8):1048-58. PMC: 4087082. DOI: 10.1016/j.jcyt.2014.01.417. View

4.
Eckert M, Vu Q, Xie K, Yu J, Liao W, Cramer S . Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab. 2013; 33(9):1322-34. PMC: 3764389. DOI: 10.1038/jcbfm.2013.91. View

5.
Ishibashi N, Scafidi J, Murata A, Korotcova L, Zurakowski D, Gallo V . White matter protection in congenital heart surgery. Circulation. 2012; 125(7):859-71. PMC: 3288390. DOI: 10.1161/CIRCULATIONAHA.111.048215. View